| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
-Dependent Pathway
Faculty of Pharmacy (R.A., A.D., K.B., D.H., S.M., H.O.), Pavillon Jean-Coutu, University of Montreal, Montréal, Québec, H3C 3J7 Canada; Research Center, Ste-Justine Hospital (R.A., A.D., A.R.-W., A.T.), and Departments of Biochemistry (A.R.-W., A.T.), and Obstetrics and Gynecology (A.T.), Faculty of Medicine, University of Montreal, Montreal, Québec, H3T 1C5 Canada; and Center for Integrative Genomics and National Center of Competence in Research Frontiers in Genetics (S.A., W.W.), University of Lausanne, CH-1015 Lausanne, Switzerland
Address all correspondence and requests for reprints to: André Tremblay, Research Center, Ste-Justine Hospital, 3175 Côte Ste-Catherine, Montréal (Québec), Canada H3T 1C5. E-mail: andre.tremblay{at}recherche-ste-justine.qc.ca; or Huy Ong, Pavillon Jean-Coutu, University of Montreal, Montréal (Québec), Canada H3C 3J7. E-mail: huy.ong{at}umontreal.ca.
Macrophages play a central role in the pathogenesis of atherosclerosis by accumulating cholesterol through increased uptake of oxidized low-density lipoproteins by scavenger receptor CD36, leading to foam cell formation. Here we demonstrate the ability of hexarelin, a GH-releasing peptide, to enhance the expression of ATP-binding cassette A1 and G1 transporters and cholesterol efflux in macrophages. These effects were associated with a transcriptional activation of nuclear receptor peroxisome proliferator-activated receptor (PPAR)
in response to binding of hexarelin to CD36 and GH secretagogue-receptor 1a, the receptor for ghrelin. The hormone binding domain was not required to mediate PPAR
activation by hexarelin, and phosphorylation of PPAR
was increased in THP-1 macrophages treated with hexarelin, suggesting that the response to hexarelin may involve PPAR
activation function-1 activity. However, the activation of PPAR
by hexarelin did not lead to an increase in CD36 expression, as opposed to liver X receptor (LXR)
, suggesting a differential regulation of PPAR
-targeted genes in response to hexarelin. Chromatin immunoprecipitation assays showed that, in contrast to a PPAR
agonist, the occupancy of the CD36 promoter by PPAR
was not increased in THP-1 macrophages treated with hexarelin, whereas the LXR
promoter was strongly occupied by PPAR
in the same conditions. Treatment of apolipoprotein E-null mice maintained on a lipid-rich diet with hexarelin resulted in a significant reduction in atherosclerotic lesions, concomitant with an enhanced expression of PPAR
and LXR
target genes in peritoneal macrophages. The response was strongly impaired in PPAR
+/ macrophages, indicating that PPAR
was required to mediate the effect of hexarelin. These findings provide a novel mechanism by which the beneficial regulation of PPAR
and cholesterol metabolism in macrophages could be regulated by CD36 and ghrelin receptor downstream effects.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
A. Tesse, G. Al-Massarani, R. Wangensteen, S. Reitenbach, M. C. Martinez, and R. Andriantsitohaina Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-{gamma} Agonist, Prevents Microparticle-Induced Vascular Hyporeactivity through the Regulation of Proinflammatory Proteins J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 539 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rodrigue-Way, A. Demers, H. Ong, and A. Tremblay A Growth Hormone-Releasing Peptide Promotes Mitochondrial Biogenesis and a Fat Burning-Like Phenotype through Scavenger Receptor CD36 in White Adipocytes Endocrinology, March 1, 2007; 148(3): 1009 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iantorno, H. Chen, J.-a Kim, M. Tesauro, D. Lauro, C. Cardillo, and M. J. Quon Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E756 - E764. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sanchez, K. Sauve, N. Picard, and A. Tremblay The Hormonal Response of Estrogen Receptor beta Is Decreased by the Phosphatidylinositol 3-Kinase/Akt Pathway via a Phosphorylation-dependent Release of CREB-binding Protein J. Biol. Chem., February 16, 2007; 282(7): 4830 - 4840. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |